Conditions, DEA and Terpenes - Medical Cannabis Brief

New U.S. Research Efforts Could Catalyze Medical Cannabis’ Adoption in the Pharmaceutical Industry

Veriheal

APRIL 11, 2022

Drug Enforcement Agency (DEA). According to the company’s CEO, George Hodgin, “federally legal FDA- and DEA-approved cannabis-based drugs will absolutely upend the traditional pharmaceutical market.”. Groff confirmed that it had completed its first batch of medicinal-grade cannabis for research purposes on Feb.

Pharmaceutical

Pharmaceutical Research and Development DEA Clinical Trials

CBD: Everything You Need to Know

CannaMD

AUGUST 8, 2020

Drugs, substances, and certain chemicals used to make drugs are classified into five categories (known as schedules ) depending on the Department of Drug Enforcement Agency (DEA)’s definition of the drug’s acceptable medical use and abuse/dependency potential. CBD Scheduling Rule Change. But the government is clear.

CBD

CBD DEA Research and Development Hemp

Is Cannabis Classified as a Hallucinogen, Stimulant, or Depressant?

Veriheal

OCTOBER 17, 2021

It can also help to treat mental health conditions, such as anxiety , depression , obsessive-compulsive disorder (OCD) , and post-traumatic stress disorder (PTSD ) in some people. In addition, the euphoric feeling you get from cannabis can vary based on the strain and its cannabinoid and terpene profile. Too Many Variables.

Terpenes

Terpenes Strains THC Cannabis

Six Things You Need to Know About CBD and Other Hemp-containing Pet Products

Cannabis Law Report

AUGUST 23, 2021

FDA has not reviewed the manufacturing process of these unapproved CBD-containing drug products, so the manufacturing conditions of, or contaminant levels in, these products is unknown. Practicing veterinarians face a barrage of questions from pet owners about the use of CBD animal products for conditions ranging from arthritis to anxiety.

Pets

Pets Hemp CBD Food

How to Talk To Your Doctor About Becoming a Legal Medical Cannabis Patient

MedicalJane

JUNE 29, 2018

Although this is exciting for many advocates of the plant, many patients that are suffering from ailing health conditions are left wondering what this means for them, and how exactly all of these changes will impact their healthcare options. Do you qualify for medical cannabis? There is no universal handbook for a medical cannabis program.

Patients

Patients Legalization Conditions Treatment

Setting it Straight on Delta-8-THC

Veriheal

DECEMBER 1, 2020

Cannabis has shifted from being conceived as a drug choice of lazy people to becoming a potent, powerful medicine that helps with many different ailments and conditions. The DEA is Already Interfering. Way to go, DEA, on jumping the gun showing your true colors. The abbreviation stands for tetrahydrocannabinol.

THC

THC DEA Research and Development Cannabinoids

Cannabis and the Environment: Seven Significant Side-Effects April 14, 2022

Cannabis Law Report

APRIL 14, 2022

Local governments may also impose zoning conditions on cannabis facilities, including but not limited to buffer zones, density conditions, hours of operation, odor control requirements, necessary operating permits, and storefront characteristics. pursuant to Drug Enforcement Agency (DEA) or state-level programs).

Environment

Environment Agriculture Compliance Compliance

Cannabis Researchers: NIH Wants to Hear From You!

Canna Law Blog

AUGUST 16, 2022

Today, many states have medical cannabis programs and the Food and Drug Administration has approved some cannabinoid-based drugs for certain conditions. As a refresher, the Drug Enforcement Administration (DEA) conducts the licensing process that enables researchers to gain access to cannabis product.

DEA

DEA Access Cannabinoids Cannabis

Minorities in cannabis, with Steven Philpott Jr.

The Cannigma

FEBRUARY 16, 2022

Well, these cannabis plants are making these trichomes, they’re fortifying and you’re telling me that the hot stuff is made in this cannabis trichomes, the cannabinoids and the terpenes, or many of the terpenes anyway? So, I’m legitimately, I’m a strength conditioning coach. Without drying?

Trichome

Trichome Wellness and Beauty Cannabinoids Cannabis

Dogs, cats and CBD: Cannabis and pets

Alchimia

APRIL 17, 2018

As research on the different cannabinoids and terpenes – and other compounds produced by the cannabis plant – advances, more and more testimonies claim that the efficacy of these substances is beyond doubt. Moreover, these products often contain other beneficial, non-psychoactive compounds like terpenes, flavonoids and vitamins.

Pets

Pets CBD Cannabinoids Extraction

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

JULY 12, 2019

There is a phenomenon known as the “entourage effect” where the action of multiple cannabinoids and other plant compounds known as terpenes exhibit effects at a variety of receptors. More research is needed to determine proper ratios for specific conditions, as well as genetic testing developed to determine appropriate course of treatment.

Extraction

Extraction Pharmaceutical CBD Epilepsy

DEA Expands Research Opportunities for Scientists Studying Cannabis

NewsMunchies

MAY 20, 2021

This action by the DEA means researchers will be able to study marijuana from more than one grower. By sourcing the plant from more than one facility, scientists can now go out and source materials focused on certain criteria, such as a high THC content, particular terpene profile, or high CBD content. Rate this blog post.

DEA

DEA Chronic Pain Terpenes Packaging

What Are Designer Drugs and How Dangerous Are They?

Veriheal

MARCH 11, 2021

The Drug Enforcement Administration, or the DEA, explains that these types of drugs are also known as new psychoactive substances (NPS) and goes on to state that there are at least 300 known designer drugs, each of which belongs to one of the following three categories of NPS. Synthetic Phenethylamines. appeared first on Cannabis Central.

Cannabinoids

Cannabinoids DEA Terpenes Packaging

What is THC? Here’s everything you need to know

The Cannigma

SEPTEMBER 12, 2021

Marijuana (defined in the US as any cannabis plant where THC>0.3%) is a schedule I drug according to the DEA and FDA. Despite advancements in research, evidence regarding the health effects of cannabis use remains elusive and there is no consensus within the medical community about which conditions it can treat.

THC

THC Research and Development Cannabinoids CBD

Medical Cannabis Brief

New U.S. Research Efforts Could Catalyze Medical Cannabis’ Adoption in the Pharmaceutical Industry

CBD: Everything You Need to Know

Trending Sources

Is Cannabis Classified as a Hallucinogen, Stimulant, or Depressant?

Six Things You Need to Know About CBD and Other Hemp-containing Pet Products

How to Talk To Your Doctor About Becoming a Legal Medical Cannabis Patient

Setting it Straight on Delta-8-THC

Cannabis and the Environment: Seven Significant Side-Effects April 14, 2022

Cannabis Researchers: NIH Wants to Hear From You!

Minorities in cannabis, with Steven Philpott Jr.

Dogs, cats and CBD: Cannabis and pets

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

DEA Expands Research Opportunities for Scientists Studying Cannabis

What Are Designer Drugs and How Dangerous Are They?

What is THC? Here’s everything you need to know

Stay Connected